1190380-65-4 Usage
Uses
Used in Pharmaceutical Industry:
1-(1-isopropylpiperidin-4-yl)-1H-pyrazol-4-amine is used as a key intermediate in the synthesis of various pharmaceutical drugs due to its unique chemical structure and potential biological activities. Its presence in drug formulations contributes to the development of medications with therapeutic effects, particularly in the areas of anticonvulsant and analgesic treatments.
Used in Agrochemical Industry:
In the agrochemical sector, 1-(1-isopropylpiperidin-4-yl)-1H-pyrazol-4-amine serves as an essential intermediate for the production of agrochemicals. Its incorporation into these products aids in the creation of effective solutions for pest control and crop protection, enhancing agricultural productivity and sustainability.
Used in Research and Development:
1-(1-isopropylpiperidin-4-yl)-1H-pyrazol-4-amine is utilized as a research compound in the exploration of new chemical entities and potential drug candidates. Its unique structure and biological activities make it a valuable tool for scientists to study and develop novel therapeutic agents and agrochemicals with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 1190380-65-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,0,3,8 and 0 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1190380-65:
(9*1)+(8*1)+(7*9)+(6*0)+(5*3)+(4*8)+(3*0)+(2*6)+(1*5)=144
144 % 10 = 4
So 1190380-65-4 is a valid CAS Registry Number.
1190380-65-4Relevant articles and documents
HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF
-
Paragraph 000231, (2020/11/30)
Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers. (I)
1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDINE-3-ONE COMPOUNDS AS INHIBITORS OF WEE-1 KINASE
-
Page/Page column 33, (2019/09/12)
The disclosure includes compounds of Formula (I) wherein Q, R1, R2, and m are defined herein. Also disclosed is a method for treating a neoplastic disease with these compounds.